SciSparc (SPRC) Competitors $6.91 -0.13 (-1.85%) Closing price 03:59 PM EasternExtended Trading$6.72 -0.19 (-2.68%) As of 06:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFDA EventsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock SPRC vs. VIRX, BPTSY, VRPX, KRBP, NCNA, TFFP, MYMD, TCBP, BON, and VINCShould you be buying SciSparc stock or one of its competitors? The main competitors of SciSparc include Viracta Therapeutics (VIRX), Biophytis (BPTSY), Virpax Pharmaceuticals (VRPX), Kiromic BioPharma (KRBP), NuCana (NCNA), TFF Pharmaceuticals (TFFP), MyMD Pharmaceuticals (MYMD), TC Biopharm (TCBP), Bon Natural Life (BON), and Vincerx Pharma (VINC). These companies are all part of the "pharmaceutical products" industry. SciSparc vs. Its Competitors Viracta Therapeutics Biophytis Virpax Pharmaceuticals Kiromic BioPharma NuCana TFF Pharmaceuticals MyMD Pharmaceuticals TC Biopharm Bon Natural Life Vincerx Pharma SciSparc (NASDAQ:SPRC) and Viracta Therapeutics (NASDAQ:VIRX) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, dividends, profitability, risk, valuation, earnings, analyst recommendations and media sentiment. Do institutionals & insiders believe in SPRC or VIRX? 25.1% of SciSparc shares are owned by institutional investors. Comparatively, 31.4% of Viracta Therapeutics shares are owned by institutional investors. 1.5% of SciSparc shares are owned by insiders. Comparatively, 10.7% of Viracta Therapeutics shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. Do analysts recommend SPRC or VIRX? Viracta Therapeutics has a consensus price target of $1.75, indicating a potential upside of 12,862.96%. Given Viracta Therapeutics' stronger consensus rating and higher possible upside, analysts plainly believe Viracta Therapeutics is more favorable than SciSparc.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score SciSparc 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Viracta Therapeutics 0 Sell rating(s) 2 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.33 Is SPRC or VIRX more profitable? SciSparc's return on equity of 0.00% beat Viracta Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets SciSparcN/A N/A N/A Viracta Therapeutics N/A -1,899.61%-114.21% Does the media refer more to SPRC or VIRX? In the previous week, SciSparc had 1 more articles in the media than Viracta Therapeutics. MarketBeat recorded 1 mentions for SciSparc and 0 mentions for Viracta Therapeutics. SciSparc's average media sentiment score of 0.00 equaled Viracta Therapeutics'average media sentiment score. Company Overall Sentiment SciSparc Neutral Viracta Therapeutics Neutral Which has higher valuation and earnings, SPRC or VIRX? SciSparc has higher revenue and earnings than Viracta Therapeutics. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSciSparc$1.31M2.80-$6.28MN/AN/AViracta TherapeuticsN/AN/A-$51.06M-$1.10-0.01 Which has more volatility & risk, SPRC or VIRX? SciSparc has a beta of 0.72, meaning that its share price is 28% less volatile than the S&P 500. Comparatively, Viracta Therapeutics has a beta of 1.06, meaning that its share price is 6% more volatile than the S&P 500. SummaryViracta Therapeutics beats SciSparc on 6 of the 11 factors compared between the two stocks. Get SciSparc News Delivered to You Automatically Sign up to receive the latest news and ratings for SPRC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SPRC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SPRC vs. The Competition Export to ExcelMetricSciSparcMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$3.76M$2.43B$5.56B$9.04BDividend YieldN/A1.79%5.25%4.03%P/E RatioN/A4.0519.5820.23Price / Sales2.80765.58442.27127.79Price / CashN/A164.1737.5058.41Price / Book0.384.698.085.60Net Income-$6.28M$31.26M$3.16B$248.43M7 Day Performance1.25%6.81%3.77%5.15%1 Month Performance-3.19%4.12%3.90%7.62%1 Year Performance-51.02%4.05%34.22%21.56% SciSparc Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SPRCSciSparcN/A$6.91-1.8%N/A-49.2%$3.76M$1.31M0.004VIRXViracta Therapeutics2.1483 of 5 stars$0.02-4.3%$1.75+11,190.3%-97.1%$616KN/A-0.0120Gap DownBPTSYBiophytisN/A$1.45flatN/A-78.6%$509KN/A0.0030VRPXVirpax Pharmaceuticals1.5872 of 5 stars$0.39+0.3%$75.00+19,130.8%-98.8%$484KN/A0.007Gap DownKRBPKiromic BioPharmaN/AN/AN/AN/A$330KN/A-0.0660Gap DownHigh Trading VolumeNCNANuCana2.5297 of 5 stars$0.05+3.6%$25.00+48,255.9%-98.0%$311KN/A-0.0130Gap UpTFFPTFF PharmaceuticalsN/A$0.07flatN/AN/A$289K$730K-0.0119MYMDMyMD PharmaceuticalsN/A$0.12+2.1%N/A-93.3%$280KN/A0.006Gap DownHigh Trading VolumeTCBPTC BiopharmN/A$0.68-55.8%$48.00+6,948.5%-99.5%$279K$4.76M0.0080High Trading VolumeBONBon Natural Life1.1387 of 5 stars$1.41+0.7%N/AN/A$240K$23.84M0.00100VINCVincerx Pharma3.0335 of 5 stars$0.04+15.2%$40.00+91,016.2%-99.7%$230KN/A0.0060News Coverage Related Companies and Tools Related Companies VIRX Alternatives BPTSY Alternatives VRPX Alternatives KRBP Alternatives NCNA Alternatives TFFP Alternatives MYMD Alternatives TCBP Alternatives BON Alternatives VINC Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SPRC) was last updated on 7/10/2025 by MarketBeat.com Staff From Our PartnersI was wrong about TrumpI made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his ...Porter & Company | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SciSparc Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share SciSparc With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SPRC Stock Alerts